Miniatura

Fitxers

TuazonAMD.pdf (3.71 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2020-10-21

Llicència de publicació

cc by (c) Tuazon et al., 2020
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/173973

Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1186/s13058-020-01341-3

Resum

Background: TheBRCA1c.3331_3334delCAAG founder mutation has been reported in hereditary breast and ovarian cancer families from multiple Hispanic groups. We aimed to evaluateBRCA1c.3331_3334delCAAG haplotype diversity in cases of European, African, and Latin American ancestry. Methods: BC mutation carrier cases from Colombia (n = 32), Spain (n = 13), Portugal (n = 2), Chile (n = 10), Africa (n = 1), and Brazil (n = 2) were genotyped with the genome-wide single nucleotide polymorphism (SNP) arrays to evaluate haplotype diversity aroundBRCA1c.3331_3334delCAAG. Additional Portuguese (n = 13) and Brazilian (n = 18) BC mutation carriers were genotyped for 15 informative SNPs surroundingBRCA1. Data were phased using SHAPEIT2, and identical by descent regions were determined using BEAGLE and GERMLINE. DMLE+ was used to date the mutation in Colombia and Iberia. Results: The haplotype reconstruction revealed a shared 264.4-kb region among carriers from all six countries. The estimated mutation age was similar to 100 generations in Iberia and that it was introduced to South America early during the European colonization period. Conclusions: Our results suggest that this mutation originated in Iberia and later introduced to Colombia and South America at the time of Spanish colonization during the early 1500s. We also found that the Colombian mutation carriers had higher European ancestry, at the BRCA1 gene harboring chromosome 17, than controls, which further supported the European origin of the mutation. Understanding founder mutations in diverse populations has implications in implementing cost-effective, ancestry-informed screening.

Matèries

Càncer de mama, Càncer d'ovari

Matèries (anglès)

Breast cancer, Ovarian cancer

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

ASIS TUAZON, Anna marie de, LOTT, Paul, BOHORQUEZ, Mabel, BENAVIDES, Jennyfer, RAMIREZ, Carolina, CRIOLLO, Angel, ESTRADA FLOREZ, Ana, MATEUS, Gilbert, VELEZ, Alejandro, CARMONA, Jenny, OLAYA, Justo, GARCIA, Elisha, POLANCO ECHEVERRY, Guadalupe, STULTZ, Jacob, ALVAREZ, Carolina, TAPIA, Teresa, ASHTON PROLLA, Patricia, VEGA, Ana, LÁZARO GARCÍA, Conxi, TORNERO, Eva, MARTINEZ BOUZAS, Cristina, INFANTE, Mar, HOYA, Miguel de la, DIEZ, Orland, BROWNING, Brian l., RANNALA, Bruce, TEIXEIRA, Manuel r., CARVALLO, Pilar, ECHEVERRY, Magdalena, CARVAJAL CARMONA, Luis g., Brazilian Familial Cancer Network, COLUMBUS Consortium. Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia. _Breast Cancer Research_. 2020. Vol. 22. [consulta: 23 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/173973]

Exportar metadades

JSON - METS

Compartir registre